Shares of Johnson & Johnson
rallied 1.05% to $170.27 Monday, on what proved to be an all-around dismal buying and selling session for the inventory market, with the S&P 500 Index
falling 1.04% to 4,188.43 and Dow Jones Industrial Common
falling 0.10% to 34,742.82. This was the inventory’s third consecutive day of good points. Johnson & Johnson closed $3.38 in need of its 52-week excessive ($173.65), which the corporate reached on January twenty sixth.
The inventory demonstrated a combined efficiency when in comparison with a few of its opponents Monday, as Roche Holding AG Half. Cert.
rose 1.20% to $337.00, Merck & Co. Inc.
fell 0.31% to $78.17, and Pfizer Inc.
rose 0.71% to $39.86. Buying and selling quantity (8.3 M) eclipsed its 50-day common quantity of seven.5 M.